Home LiteratureArticle Details
PMID: 6343827 Published · ppublish English Journal Article Review

Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Microbiological reviews ·Vol. 47 ·No. 1 ·1983-03-00 ·Pages 46-83

Taylor PW

Abstract

暂无摘要

MeSH Terms
Animals Bacteria/immunology Bacterial Infections/immunology Blood Bactericidal Activity Cell Membrane/immunology Complement Activation Complement System Proteins/immunology Guinea Pigs Humans Hydrogen-Ion Concentration Immunity Immunoglobulins/immunology Lipopolysaccharides/physiology Muramidase/physiology Plasmids Polysaccharides, Bacterial/physiology Rabbits Rats
Chemicals
Immunoglobulins Lipopolysaccharides Polysaccharides, Bacterial Complement System Proteins Muramidase
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Taylor P W
References (280)
280 references, click to expand
  1. Mechanism of action of specific antiserum on Pasteurella septica. Selective inhibition of net macromolecular synthesis and its reversal by iron compounds.
    Eur J Biochem. 1971 Nov 11;23(1):69-76 PMID: 5166689
  2. Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.
    Proc Natl Acad Sci U S A. 1982 Jan;79(2):574-8 PMID: 6952208
  3. Sensitization of complement-resistant smooth gram-negative bacterial strains.
    Infect Immun. 1971 Mar;3(3):365-72 PMID: 16557981
  4. Antibacterial peptide from normal rat serum. 1. Isolation from whole serum, activity, and microbicidal spectrum.
    Biochemistry. 1981 Oct 13;20(21):5973-81 PMID: 6796108
  5. Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100.
    J Immunol. 1980 Oct;125(4):1494-8 PMID: 6997381
  6. Activity of mitomycin C, other antibiotics, and serum against lysogenic bacteria.
    J Bacteriol. 1966 Oct;92(4):967-71 PMID: 4288803
  7. Heterogeneity of the lipopolysaccharide from Pseudomonas aeruginosa.
    Eur J Biochem. 1975 Oct 15;58(2):273-82 PMID: 810351
  8. Immunological and physiological characteristics of the rapid immune hemolysis of neuraminidase-treated sheep red cells produced by fresh guinea pig serum.
    J Exp Med. 1975 Oct 1;142(4):974-88 PMID: 1185109
  9. Inactivation of bacteriophage T4, of poly-D-alanyl bacteriophage and of penicilloyl bacteriophage by immunospecifically isolated IgM and IgG antibodies.
    J Immunol. 1969 Jul;103(1):45-55 PMID: 5796859
  10. Experimental Escherichia coli urinary infection in the rat.
    Kidney Int. 1975 Oct;8(4):233-8 PMID: 1104967
  11. Electron spin resonance studies on interaction of complement proteins with erythrocyte membranes.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):4930-4 PMID: 217005
  12. Antibacterial mechanisms in the urinary bladder.
    Yale J Biol Med. 1967 Oct;40(2):93-108 PMID: 4868226
  13. Opsonizing and bactericidal activity of antibodies against common antigen of Enterobacteriaceae.
    J Bacteriol. 1966 Jan;91(1):129-33 PMID: 4955466
  14. Humoral bactericidal systems: nonspecific and specific mechanisms.
    Infect Immun. 1978 Feb;19(2):515-22 PMID: 344215
  15. THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.
    J Exp Med. 1965 Aug 1;122:385-402 PMID: 14316950
  16. [Serum resistance and "nephropathogenicity" of antigenetically defined E. coli strains. 3. Experimental pyelonephritis with differently serum resistant bacilli].
    Z Med Mikrobiol Immunol. 1971;156(3):297-304 PMID: 4934920
  17. Inherited deficiency of the ninth component of complement in man.
    J Immunol. 1980 Nov;125(5):2252-7 PMID: 7430628
  18. Chemical studies on damages of Escherichea coli by the immune bactericidal reaction. II. Release of phosphatidylethanolamine from a phospholipase A-deficient mutant of E. coli during the immune bactericidal reaction.
    Biken J. 1974 Dec;17(4):135-40 PMID: 4619010
  19. A new polysaccharide resembling alginic acid isolated from pseudomonads.
    J Biol Chem. 1966 Aug 25;241(16):3845-51 PMID: 5916397
  20. The true division and death rates of Salmonella typhimurium in the mouse spleen determined with superinfecting phage P22.
    Br J Exp Pathol. 1968 Dec;49(6):597-613 PMID: 4884387
  21. Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals.
    Infect Immun. 1980 Jul;29(1):200-6 PMID: 6995336
  22. Meningococcal meningitis in familial deficiency of the fifth component of complement.
    Pediatrics. 1981 Jun;67(6):882-6 PMID: 6785713
  23. Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.
    Infect Immun. 1980 May;28(2):359-67 PMID: 6995306
  24. Frequency of E. coli K antigens in urinary-tract infections in children.
    Lancet. 1977 Mar 26;1(8013):663-6 PMID: 66470
  25. Effect of the growth environment on cell-envelope components of Escherichia coli in relation to sensitivity to human serum.
    J Med Microbiol. 1981 Feb;14(1):9-19 PMID: 7007647
  26. Immunochemical studies of polysaccharide surface antigens of Escherichia coli 0100:K?(B):H2.
    Eur J Biochem. 1970 Jul;15(1):29-39 PMID: 4321381
  27. Susceptibility of isolates of Bacteroides to the bactericidal activity of normal human serum.
    J Infect Dis. 1979 Jul;140(1):109-13 PMID: 458196
  28. On the mechanism of membrane damage by complement: the effect of length and unsaturation of the acyl chains in liposomal bilayers and the effect of cholesterol concentration in sheep erythrocyte and liposomal membranes.
    J Immunol. 1978 Jun;120(6):1996-2002 PMID: 659889
  29. Bacteriolysis of Enterobacteriaceae. I. Lysis by four lytic systems utilizing lysozyme.
    J Bacteriol. 1961 Mar;81:482-91 PMID: 13729468
  30. Immunological activity of precolostral calf serum.
    Nature. 1959 Mar 21;183(4664):838 PMID: 13644215
  31. Effects of serum components on gram-negative bacteria during bactericidal reactions.
    Infect Immun. 1971 Jan;3(1):107-15 PMID: 16557925
  32. Plasmid carriage and the serum sensitivity of enterobacteria.
    Infect Immun. 1978 Oct;22(1):10-7 PMID: 365738
  33. The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.
    Immunology. 1971 May;20(5):767-77 PMID: 4950867
  34. Chemical studies on damages of Escherichia coli by the immune bactericidal reaction. I. Release and degradation of phospholipids from damaged bacteria.
    Biken J. 1974 Dec;17(4):127-34 PMID: 4619009
  35. Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease.
    J Infect Dis. 1977 Dec;136(6):733-9 PMID: 925381
  36. Uridinediphosphogalactose-4-epimerase deficiency in Salmonella typhimurium and its correction by plasmoid-borne galactose genes of Escherichia coli K-12: effects on mouse virulence, phagocytosis, and serum sensitivity.
    Infect Immun. 1971 Sep;4(3):177-88 PMID: 4949486
  37. Killing of an encapsulated strain of Escherichia coli by human serum.
    Infect Immun. 1983 Jan;39(1):122-31 PMID: 6185430
  38. Relationship between bactericidal action of complement and fluidity of cellular membranes.
    Infect Immun. 1978 Jan;19(1):12-7 PMID: 342407
  39. THE EFFECT OF THE GROWTH RATE ON THE COMPOSITION OF S. ENTERITIDIS CELL WALLS.
    Aust J Exp Biol Med Sci. 1964 Apr;42:255-62 PMID: 14150760
  40. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
    J Lab Clin Med. 1976 Feb;87(2):206-17 PMID: 1107450
  41. THE EPIDEMIOLOGY OF NONENTERIC ESCHERICHIA COLI INFECTIONS. II. RELATIONSHIP OF PREVALENCE OF E. COLI IN URINARY INFECTIONS TO THE BACTERICIDAL EFFECT OF HUMAN SERUM.
    J Lab Clin Med. 1964 Jun;63:901-6 PMID: 14179124
  42. The activation mechanism of human complement system by immune precipitate formed with rabbit IgG antibody.
    Microbiol Immunol. 1979;23(10):1023-31 PMID: 514094
  43. Locus of the lethal event in the serum bactericidal reaction.
    J Bacteriol. 1968 Dec;96(6):2127-31 PMID: 4881704
  44. VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.
    Biochemistry. 1964 Jul;3:996-1008 PMID: 14214095
  45. The sensitivity to complement of strains of Escherichia coli related to their K antigens.
    Immunology. 1970 Mar;18(3):331-46 PMID: 4986073
  46. Effect of lysogeny on serum sensitivity.
    J Bacteriol. 1968 Dec;96(6):1912-4 PMID: 4881698
  47. Dog immunoglobulins. II. The antibacterial properties of dog IgA, IgM and IgG antibodies to Vibrio cholerae.
    Immunology. 1975 Jul;29(1):197-208 PMID: 1140826
  48. Sensitivity of some smooth strains of Escherichia coli to the bactericidal action of normal human serum.
    J Clin Pathol. 1974 Aug;27(8):626-9 PMID: 4608427
  49. Serology, chemistry, and genetics of O and K antigens of Escherichia coli.
    Bacteriol Rev. 1977 Sep;41(3):667-710 PMID: 334154
  50. Bacteriolysis of Enterobacteriaceae. II. Pre- and co-lytic treatments potentiating the action of lysozyme.
    J Bacteriol. 1961 Mar;81:492-9 PMID: 13729469
  51. Haemophilus influenzae meningitis in an adult. A study of bactericidal antibodies and immunoglobulins.
    N Engl J Med. 1970 Jan 22;282(4):190-4 PMID: 4188313
  52. Human serum complement requirements for bacterial killing and protoplast lysis of Escherichia coli ML308 225.
    J Gen Microbiol. 1981 Mar;123(1):179-81 PMID: 7033454
  53. Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.
    Infect Immun. 1980 Jun;28(3):735-45 PMID: 6156906
  54. Determinants that increase the serum resistance of Escherichia coli.
    Infect Immun. 1980 Jul;29(1):278-80 PMID: 6995340
  55. A new method for the extraction of R lipopolysaccharides.
    Eur J Biochem. 1969 Jun;9(2):245-9 PMID: 5804498
  56. The survival of strains of enteric bacilli in the blood stream as related to their sensitivity to the bactericidal effect of serum.
    J Clin Invest. 1960 Jan;39:82-8 PMID: 14437724
  57. Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.
    Infect Immun. 1976 May;13(5):1343-6 PMID: 818023
  58. Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94.
    Infect Immun. 1982 Feb;35(2):654-9 PMID: 7035371
  59. Molecular transport via the functional complement lesion.
    Mol Immunol. 1980 Dec;17(12):1465-74 PMID: 6795446
  60. Mechanism of colicin action: early events.
    J Bacteriol. 1970 Dec;104(3):1236-41 PMID: 16559098
  61. Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems.
    J Bacteriol. 1968 Oct;96(4):1339-48 PMID: 4879562
  62. The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes.
    Immunology. 1975 Jun;28(6):1061-6 PMID: 1093969
  63. Depression of phagocytosis by solutes in concentrations found in the kidney and urine.
    J Clin Invest. 1962 Oct;41:1945-53 PMID: 14020591
  64. Release of lipopolysaccharide by EDTA treatment of E. coli.
    Biochem Biophys Res Commun. 1965 Nov 22;21(4):290-6 PMID: 4159978
  65. Spot method in agar for the quantitative assay of anti-Salmonella antibody.
    Jpn J Microbiol. 1968 Sep;12(3):364-6 PMID: 5304545
  66. Lipid phase transitions in cytoplasmic and outer membranes of Escherichia coli.
    Biochim Biophys Acta. 1975 May 6;389(2):358-69 PMID: 1095062
  67. Complement-induced modifications in membrane fluidity: studies with resealed and glutaraldehyde-treated erythrocyte membrane ghosts.
    J Immunol. 1978 Jun;120(6):2003-7 PMID: 207778
  68. Membrane attack complex of complement. Evidence for its dimeric structure based on hybrid formation.
    J Biol Chem. 1981 Apr 10;256(7):3145-8 PMID: 7204396
  69. Effects of colicins E1 and K on transport systems.
    J Bacteriol. 1969 Jan;97(1):57-63 PMID: 4884823
  70. Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus.
    Infect Immun. 1981 Sep;33(3):666-72 PMID: 7287175
  71. Sensitivity of gram-negative bacilli to the serum bactericidal activity: a marker of the host-parasite relationship in acute and persisting infections.
    Scand J Infect Dis Suppl. 1977;(10):1-40 PMID: 339328
  72. Comparative bactericidal activities of blood serum and plasma serum.
    J Exp Med. 1960 Jul 1;112:15-22 PMID: 13714580
  73. [Serum resistance and "nephropathogenicity" of antigenetically defined E. coli strains. II. Behavior of different serum resistant bacilli in vitro].
    Z Med Mikrobiol Immunol. 1971;156(3):284-96 PMID: 4934919
  74. Immune bactericidal reactions by guinea-pig gamma1 and gamma2 antibodies.
    Immunology. 1976 Mar;30(3):435-41 PMID: 815178
  75. Studies on antibacterial factors in mammalian tissues and fluids. I. A serum bactericidin for Bacillus subtilis.
    J Immunol. 1955 Jan;74(1):9-16 PMID: 13233512
  76. Studies on the Effect of Immune Reactions on the Metabolism of Bacteria: I. Methods and Results with Eberthella typhosa.
    J Bacteriol. 1948 Mar;55(3):381-92 PMID: 16561469
  77. Serological Properties of gammaG and gammaM Antibodies to the Somatic Antigen of Vibrio cholerae During the Course of Immunization of Rabbits.
    Infect Immun. 1971 Jun;3(6):803-9 PMID: 16558058
  78. Quantitative studies on the bactericidal actions of serum and complement. I. A rapid photometric growth assay for bactericidal activity.
    J Immunol. 1956 Jan;76(1):1-10 PMID: 13295581
  79. The properdin system and immunity. V. The bactericidal activity of the properdin system.
    J Exp Med. 1956 May 1;103(5):553-75 PMID: 13319578
  80. K antigens of Escherichia coli and renal involvement in urinary-tract infections.
    Lancet. 1971 Mar 13;1(7698):514-6 PMID: 4100434
  81. Analysis of solute diffusion across the C5b-9 membrane lesion of complement: evidence that individual C5b-9 complexes do not function as discrete, uniform pores.
    J Immunol. 1980 Dec;125(6):2617-25 PMID: 7430641
  82. Role of bacterial phospholipases in serum-mediated killing of Escherichia coli.
    Infect Immun. 1977 Oct;18(1):183-8 PMID: 332640
  83. CHARACTERIZATION OF THE BACTERICIDAL ACTION OF PRECOLOSTRAL PIGLET AND CALF SERA AGAINST GRAM NEGATIVE ENTERIC BACTERIA IN ROUGH PHASE.
    Folia Microbiol (Praha). 1965 May;10:145-55 PMID: 14344772
  84. Reaction mechanisms of nascent C567 (reactive lysis). II. Killing of a rough form of Escherichia coli by C567, C8, and C9.
    J Infect Dis. 1974 Apr;129(4):444-50 PMID: 4206245
  85. SOME ASPECTS OF THE ANTIBODY RESPONSE OF RABBITS TO IMMUNIZATION WITH ENTEROBACTERIAL SOMATIC ANTIGENS.
    Proc Soc Exp Biol Med. 1964 Jul;116:832-7 PMID: 14194672
  86. Protective role of complement in experimental Escherichia coli endocarditis.
    Infect Immun. 1977 Apr;16(1):213-7 PMID: 326670
  87. Interaction of complement components with a serum-resistant strain of Salmonella typhimurium.
    Infect Immun. 1975 May;11(5):944-8 PMID: 804448
  88. Molecular cloning of the K1 capsular polysaccharide genes of E. coli.
    Nature. 1981 Feb 19;289(5799):696-8 PMID: 7007894
  89. Suppression of blood group agglutinability of human erythrocytes by certain bacterial polysaccharides.
    J Exp Med. 1963 Mar 1;117:321-38 PMID: 14019651
  90. K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains.
    Infect Immun. 1978 Oct;22(1):219-24 PMID: 103825
  91. In vivo bactericidal activity of mouse complement against Escherichia coli.
    Br J Exp Pathol. 1970 Oct;51(5):498-506 PMID: 4923650
  92. Sensitivity of rough gram-negative bacteria to the bactericidal action of serum.
    J Bacteriol. 1968 May;95(5):1647-50 PMID: 5650074
  93. PREVENTION OF PYELONEPHRITIS BY WATER DIURESIS: EVIDENCE FOR THE ROLE OF MEDULLARY HYPERTONICITY IN PROMOTING RENAL INFECTION.
    J Clin Invest. 1965 Jan;44:73-9 PMID: 14254258
  94. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.
    J Pediatr. 1976 Dec;89(6):892-7 PMID: 792409
  95. Colicin V production by clinical isolates of Escherichia coli.
    Infect Immun. 1981 Feb;31(2):574-9 PMID: 7012013
  96. Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes.
    Scand J Immunol. 1978;7(1):45-6 PMID: 635472
  97. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).
    J Immunol. 1977 Jan;118(1):362-8 PMID: 318670
  98. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    J Immunol. 1981 Nov;127(5):1748-54 PMID: 6795260
  99. Endotoxic properties of gramnegative bacteria and their susceptibility to the lethal effect of normal serum.
    J Infect Dis. 1961 Jan-Feb;108:90-4 PMID: 13770152
  100. [Studies on the immune bacteriolysis. XIV. Requirement of all nine components of complement for immune bacteriolysis].
    Biken J. 1968 Sep;11(3):203-6 PMID: 4888628
  101. The role of C9 in complement-mediated killing of Neisseria.
    J Immunol. 1981 Dec;127(6):2386-90 PMID: 6795273
  102. Transiently acquired serum resistance by cell-grown Escherichia coli.
    J Infect Dis. 1966 Apr;116(2):231-7 PMID: 5325782
  103. Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum.
    Infect Immun. 1977 Nov;18(2):278-82 PMID: 336539
  104. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.
    N Engl J Med. 1974 May 30;290(22):1216-20 PMID: 4133095
  105. Effects of immunization of guinea pigs lacking bactericidal antibody against Salmonella enteritidis.
    J Immunol. 1966 Aug;97(2):224-30 PMID: 5331879
  106. Dissociation and Sensitiveness to Normal Serum in Dysentery Bacilli of Type III.
    J Bacteriol. 1932 Oct;24(4):301-16 PMID: 16559588
  107. A plaque assay on agar for detection of gram-negative bacilli sensitive to complement.
    J Immunol. 1972 Nov;109(5):1156-8 PMID: 4562427
  108. The significance of serum-sensitive bacilli in gram-negative bacteremia.
    Scand J Infect Dis. 1978;10(3):203-7 PMID: 362514
  109. Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction.
    J Infect Dis. 1974 Sep;130(3):240-7 PMID: 4213017
  110. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.
    J Infect Dis. 1978 Jul;138(1):33-41 PMID: 355575
  111. Transient 19S gammaglobulin deficiency in the newborn infant, and its significance.
    Pediatrics. 1963 Feb;31:197-208 PMID: 13948240
  112. Leukocyte phagocytosis and serum bactericidal activity in chronic renal failure.
    Am J Med Sci. 1972 Nov;264(5):385-93 PMID: 4631000
  113. Serum mediated killing of three group D salmonellas.
    J Gen Microbiol. 1967 Feb;46(2):247-53 PMID: 6029733
  114. Escherichia coli and the human gut: some ecological considerations.
    J Appl Bacteriol. 1981 Aug;51(1):1-16 PMID: 7024231
  115. Quantitative studies on spheroplast formation by the complement system and lysozyme on gram negative bacteria.
    Proc Soc Exp Biol Med. 1967 Apr;124(4):1029-33 PMID: 5337604
  116. The effect of urine osmolality and pH on the bactericidal activity of plasma.
    Clin Sci. 1967 Dec;33(3):471-80 PMID: 4865557
  117. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency.
    J Lab Clin Med. 1980 Mar;95(3):362-72 PMID: 6986445
  118. Disassembly of viral membranes by complement independent of channel formation.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5843-7 PMID: 93283
  119. STUDIES OF GONOCOCCAL INFECTION. II. THE BACTERIOLYTIC POWER OF THE WHOLE DEFIBRINATED BLOOD OF PATIENTS WITH GONOCOCCAL ARTHRITIS.
    J Clin Invest. 1937 Mar;16(2):177-83 PMID: 16694466
  120. Immunochemical analyses of membrane-bound complement. Detection of the terminal complement complex and its similarity to "intrinsic" erythrocyte membrane proteins.
    Biochim Biophys Acta. 1975 Sep 16;406(1):21-35 PMID: 809065
  121. Effect of hypertonic sucrose upon the immune bactericidal reaction.
    Infect Immun. 1970 Jan;1(1):51-5 PMID: 16557692
  122. Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis.
    Proc Natl Acad Sci U S A. 1979 Mar;76(3):1410-4 PMID: 220614
  123. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
    J Infect Dis. 1972 Sep;126(3):257-76 PMID: 4626509
  124. Lysis of gram-negative bacteria by serum.
    J Gen Microbiol. 1958 Apr;18(2):529-33 PMID: 13525670
  125. Activation of the complement system during infections due to gram-negative bacteria.
    Clin Immunol Immunopathol. 1976 May;5(3):293-302 PMID: 776471
  126. Molecular nature of the complement lesion.
    Proc Natl Acad Sci U S A. 1978 Nov;75(11):5655-9 PMID: 281714
  127. Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains.
    Antimicrob Agents Chemother. 1981 May;19(5):786-8 PMID: 6271047
  128. A kinetic study of the bacteriolytic and bactericidal action of human serum.
    Immunology. 1967 Jun;12(6):639-53 PMID: 5338688
  129. Antibacterial mechanisms of the mouse gut. I. Kinetics of infection by Salmonella typhi-murium in normal and streptomycin-treated mice studied with abortive transductants.
    Br J Exp Pathol. 1963 Apr;44:197-208 PMID: 13935360
  130. Human seminal plasma inhibition of complement.
    J Lab Clin Med. 1980 Oct;96(4):582-91 PMID: 6775032
  131. Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.
    J Infect Dis. 1976 Jan;133(1):37-45 PMID: 54397
  132. Isolation and characterization of a serum antibactericidal factor.
    Clin Sci. 1972 Nov;43(5):705-8 PMID: 4563468
  133. Characterization of the virulence and antigenic structure of Salmonella typhimurium strains with lipopolysaccharide core defects.
    Infect Immun. 1976 Jun;13(6):1539-42 PMID: 786875
  134. Complement-mediated immune mechanisms in renal infection.
    Clin Exp Immunol. 1978 Jul;33(1):107-14 PMID: 709907
  135. Antibacterial peptide from normal rabbit serum. 2. Compositional microanalysis.
    Biochemistry. 1981 Oct 13;20(21):5981-7 PMID: 7306487
  136. Phenotypic changes in the resistance of Neisseria gonorrhoeae to killing by normal human serum.
    J Gen Microbiol. 1977 Nov;103(1):69-75 PMID: 412918
  137. Effects of antibiotic resistance plasmids on the bactericidal activity of normal rabbit serum.
    Infect Immun. 1978 Mar;19(3):861-6 PMID: 346487
  138. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
    J Infect Dis. 1979 Oct;140(4):581-9 PMID: 229175
  139. Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance.
    Nature. 1979 Jun 28;279(5716):778-81 PMID: 377103
  140. Deficiency of serum bactericidal activity against Salmonella typhimurium in sickle cell anaemia.
    Clin Exp Immunol. 1977 Nov;30(2):262-70 PMID: 342154
  141. Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections.
    J Med Microbiol. 1976 Nov;9(4):405-21 PMID: 794476
  142. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
    J Immunol. 1972 Sep;109(3):477-86 PMID: 4403402
  143. STUDIES RELATING TO THE SERUM RESISTANCE OF CERTAIN GRAM-NEGATIVE BACTERIA.
    J Exp Med. 1964 Jan 1;119:41-51 PMID: 14115824
  144. The isolation and biologic activities of purified secretory IgA and IgG anti-Salmonella typhimurium "O" antibodies from rabbit intestinal fluid and colostrum.
    J Immunol. 1971 Jan;106(1):181-90 PMID: 5543709
  145. Serum factors responsible for killing of Shigella.
    Immunology. 1974 Jan;26(1):205-15 PMID: 4846468
  146. Cell--cell interactions in conjugating Escherichia coli: role of traT protein in surface exclusion.
    Proc Natl Acad Sci U S A. 1977 Nov;74(11):5104-8 PMID: 337311
  147. Factors involved in bactericidal activity of sheep serum.
    Am J Vet Res. 1975 Aug;36(08):1183-7 PMID: 1098531
  148. Blocking serum lysis of Brucella abortus by hyperimmune rabbit immunoglubulin A.
    J Immunol. 1971 Jul;107(1):41-6 PMID: 4103920
  149. Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum.
    Infect Immun. 1976 Sep;14(3):848-50 PMID: 786896
  150. Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq).
    Proc Natl Acad Sci U S A. 1972 Jan;69(1):65-8 PMID: 4109599
  151. Recurrent bacterial meningitis in patients with genetic defects of terminal complement components.
    Clin Exp Immunol. 1980 Apr;40(1):16-24 PMID: 7389212
  152. The Action of Ammonia on Complement. The Fourth Component.
    Biochem J. 1926;20(5):1028-35 PMID: 16743737
  153. A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.
    J Clin Invest. 1960 Jan;39(1):72-81 PMID: 16695824
  154. The proteolytic activation systems of complement.
    Annu Rev Biochem. 1981;50:433-64 PMID: 7023363
  155. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.
    Clin Exp Immunol. 1975 Jan;19(1):121-30 PMID: 54231
  156. The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections.
    Infection. 1973;1(1):24-8 PMID: 4594781
  157. Effect of variations in lipopolysaccharide on the fluidity of the outer membrane of Escherichia coli.
    J Biol Chem. 1977 Mar 25;252(6):2077-81 PMID: 191452
  158. The structure of di- and tetrasaccharides released from cell walls by lysozyme and Streptomyces F 1 enzyme and the beta(1 to 4) N-acetylhexos-aminidase activity of these enzymes.
    Biochim Biophys Acta. 1959 Dec;36:552-4 PMID: 14441093
  159. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    J Exp Med. 1982 Mar 1;155(3):809-19 PMID: 6801180
  160. Bactericidal activity of normal serum against bacterial cultures. II. Activity against Eschericha coli strains.
    Proc Soc Exp Biol Med. 1960 Mar;103:632-6 PMID: 14425475
  161. Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2.
    Eur J Biochem. 1980;107(1):145-53 PMID: 6156828
  162. Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations.
    J Lab Clin Med. 1981 Oct;98(4):511-8 PMID: 6793679
  163. Reduction of membrane potential, an immediate effect of colicin K.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2483-7 PMID: 27788
  164. Sensitization of complement resistant bacterial strains.
    Nature. 1969 Mar 29;221(5187):1259-61 PMID: 4975337
  165. A simple bactericidal antibody test for sero-diagnosis of typhoid fever.
    J Immunol Methods. 1981;42(1):121-5 PMID: 7240754
  166. Human immunity to the meningococcus. II. Development of natural immunity.
    J Exp Med. 1969 Jun 1;129(6):1327-48 PMID: 4977281
  167. Antibacterial action of antibody and complement.
    J Infect Dis. 1973 Jul;128:Suppl:170-5 PMID: 4124213
  168. Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction.
    J Bacteriol. 1968 Dec;96(6):2118-26 PMID: 4972918
  169. Cell wall composition and virulence in Escherichia coli.
    J Exp Med. 1968 Sep 1;128(3):399-414 PMID: 4875325
  170. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
    J Exp Med. 1978 Dec 1;148(6):1722-7 PMID: 722244
  171. Phagocytosis of serum-resistant and serum-sensitive coliform bacteria (Klebsiella) by bovine neutrophils from blood and mastitic milk.
    Am J Vet Res. 1978 Mar;39(3):425-7 PMID: 637390
  172. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.
    J Exp Med. 1970 Apr 1;131(4):629-41 PMID: 4193934
  173. K antigen and serum sensitivity of rough Escherichia coli.
    Infect Immun. 1982 Sep;37(3):956-60 PMID: 6752031
  174. A four-year follow-up of schoolgirls with untreated covert bacteriuria: bacteriological aspects.
    Clin Nephrol. 1981 Oct;16(4):169-71 PMID: 7028335
  175. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
    J Clin Invest. 1979 May;63(5):912-921 PMID: 376551
  176. How complement kills E. coli. II. The apparent two-hit nature of the lethal event.
    J Immunol. 1981 Sep;127(3):1152-6 PMID: 7021676
  177. KINETICS OF THE BACTERICIDAL ACTION OF NORMAL SERUM ON GRAM-NEGATIVE BACTERIA.
    J Immunol. 1965 Jul;95:75-9 PMID: 14322582
  178. Serum bactericidal activity in patients with upper and lower urinary tract infections.
    Clin Sci. 1972 Jul;43(1):13-22 PMID: 4557280
  179. Rapid method for determining serum bactericidal activity.
    Appl Microbiol. 1974 Jan;27(1):185-6 PMID: 4589128
  180. Lysozyme and serum bactericidal action.
    Nature. 1966 May 28;210(5039):950-1 PMID: 5335505
  181. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.
    J Exp Med. 1968 Nov 1;128(5):1049-57 PMID: 4176223
  182. Studies on the immune bacteriolysis. 13. Leakage of enzymes from Escherichia coli during immune bacteriolysis.
    Biken J. 1968 Sep;11(3):193-201 PMID: 4888627
  183. Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants.
    Infect Immun. 1982 Jan;35(1):270-5 PMID: 7033137
  184. Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. I. Loss of label, death, and ultrastructural damage.
    J Bacteriol. 1966 Jan;91(1):393-400 PMID: 5323295
  185. Release of 51Cr-endotoxin from bacteria as an assay of serum bactericidal activity.
    J Immunol. 1974 Jun;112(6):2184-92 PMID: 4596698
  186. Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system.
    Am J Med Sci. 1970 Feb;259(2):114-9 PMID: 4905231
  187. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Pediatr Res. 1976 Feb;10(2):82-7 PMID: 1107953
  188. Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli.
    J Immunol. 1977 Jul;119(1):65-72 PMID: 326965
  189. A proposed mechanism for natural immunity to enterobacterial pathogens.
    J Immunol. 1968 Feb;100(2):292-306 PMID: 4867488
  190. Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.
    Infect Immun. 1978 Nov;22(2):308-11 PMID: 365753
  191. Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria.
    Acta Paediatr Scand. 1975 May;64(3):432-6 PMID: 1098383
  192. The virulence of strains of Bacterium coli for mice.
    Br J Exp Pathol. 1954 Dec;35(6):528-38 PMID: 13230409
  193. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    J Exp Med. 1982 Mar 1;155(3):797-808 PMID: 6801179
  194. Action of polymyxin B on bacterial membranes. 1. Binding to the O-antigenic lipopolysaccharide of Salmonella typhimurium.
    Z Naturforsch C. 1973 Jul-Aug;28(7):422-30 PMID: 4358580
  195. Effects of human and rabbit serum on viability, permeability, and envelope lipids of Serratia marcescens.
    Infect Immun. 1975 Apr;11(4):758-66 PMID: 1091552
  196. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency.
    Ann Intern Med. 1979 Jun;90(6):917-20 PMID: 109025
  197. Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B.
    Infect Immun. 1976 Jan;13(1):298-301 PMID: 175019
  198. Analyses of lipopolysaccharides extracted from penicillin-resistant, serum-sensitive salmonella mutants.
    J Gen Microbiol. 1967 Aug;48(2):179-88 PMID: 5341578
  199. The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia to Escherichia coli.
    Folia Microbiol (Praha). 1979;24(2):143-52 PMID: 378780
  200. The chemistry and biosynthesis of selected bacterial capsular polymers.
    Annu Rev Microbiol. 1979;33:519-60 PMID: 386932
  201. Serological properties of gamma-A antibodies to Escherichia coli present in human colostrum.
    Immunology. 1966 Jun;10(6):517-26 PMID: 5330427
  202. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).
    N Engl J Med. 1970 Feb 12;282(7):350-4 PMID: 4188976
  203. Antibody-independent interaction of the first component of complement with Gram-negative bacteria.
    Infect Immun. 1978 Oct;22(1):5-9 PMID: 365750
  204. A method for the quantitative determination of lysozyme activity in blood.
    Am J Dig Dis. 1954 Nov;21(11):327-31 PMID: 13207073
  205. The reactivity of serum against protoplasts and spheroplasts.
    J Immunol. 1966 Jul;97(1):46-51 PMID: 4958551
  206. Effect of agents that produce membrane disorder on lysis of erythrocytes by complement.
    Proc Natl Acad Sci U S A. 1981 Apr;78(4):2522-5 PMID: 6941304
  207. The specific secondary biological activities of rabbit IgM and IgG anti-Salmonella typhimurium 'O' antibodies isolated during the development of the immune response.
    Immunology. 1972 Aug;23(2):159-70 PMID: 4560740
  208. Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M.
    Science. 1966 May 27;152(3726):1257-9 PMID: 5327885
  209. Serum resistance and hemagglutination ability of marine vibrios pathogenic for fish.
    Infect Immun. 1981 Dec;34(3):702-7 PMID: 7333667
  210. Membrane damage by complement.
    Johns Hopkins Med J. 1981 Jun;148(6):243-58 PMID: 7014970
  211. Characteristics of the inhibition by rabbit immune serum of the bactericidal effect of cattle normal serum on Salmonella typhimurium 395 MRO.
    Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(6):891-9 PMID: 4566668
  212. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    J Immunol. 1982 Feb;128(2):707-11 PMID: 7033382
  213. How complement kills E. coli. I. Location of the lethal lesion.
    J Immunol. 1981 Sep;127(3):1146-51 PMID: 6267132
  214. The influence of growth conditions on the composition of some cell wall components of Aerobacter aerogenes.
    Biotechnol Bioeng. 1969 Sep;11(5):775-83 PMID: 5361170
  215. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.
    J Immunol. 1978 Dec;121(6):2174-80 PMID: 363940
  216. Dynamics of pyrene fluorescence in Escherichia coli membrane vesicles.
    Biochemistry. 1974 Mar 12;13(6):1135-9 PMID: 4592469
  217. The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity.
    Eur J Biochem. 1976 Jun 1;65(2):403-8 PMID: 949975
  218. ASSOCIATION OF "NATURAL" ANTIBODIES TO GRAM-NEGATIVE BACTERIA WITH THE GAMMA-1-MACROGLOBULINS.
    J Exp Med. 1963 Oct 1;118:619-26 PMID: 14067909
  219. Penicillin sensitivity and serum resistance are independent attributes of strains of Neisseria gonorrhoeae causing disseminated gonococcal infection.
    Infect Immun. 1977 Mar;15(3):834-41 PMID: 404247
  220. Spontaneous colon bacillus bacteremia in Laennec's cirrhosis.
    Gastroenterology. 1961 Jan;40:141-8 PMID: 13777031
  221. Susceptibility to polymyxin B in penicillin G-induced Proteus mirabilis L forms and spheroplasts.
    J Bacteriol. 1969 May;98(2):347-50 PMID: 4306537
  222. Nature and Heterogeneity of the Antigens of Neisseria gonorrhoeae Involved in the Serum Bactericidal Reaction.
    Infect Immun. 1970 Aug;2(2):162-8 PMID: 16557815
  223. Comparison of the bactericidal activity of different vertebrate sera.
    J Bacteriol. 1966 Jan;91(1):106-12 PMID: 5323292
  224. The complement system of rainbow trout (Salmo gairdneri). I. Identification of the serum lytic system homologous to mammalian complement.
    J Immunol. 1981 Apr;126(4):1489-94 PMID: 6782161
  225. The decisive period in the primary infection of muscle by Escherichia coli.
    Br J Exp Pathol. 1973 Feb;54(1):99-109 PMID: 4570251
  226. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Immunology. 1980 Aug;40(4):547-56 PMID: 6776034
  227. Outer membrane of Salmonella typhimurium. Electron spin resonance studies.
    Biochim Biophys Acta. 1977 Feb 14;465(1):152-64 PMID: 189812
  228. Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model.
    J Infect Dis. 1976 Jul;134(1):1-7 PMID: 820812
  229. The anticomplementary effect of kidney tissue; its association with ammonia production.
    J Exp Med. 1959 Nov 1;110:685-97 PMID: 13798253
  230. Ultrastructure of human C1q protein.
    Nat New Biol. 1972 Jul 26;238(82):117-8 PMID: 4625706
  231. The sensitivity of smooth and rough mutants of Salmonella typhimurium to bactericidal and bacteriolytic action of serum, lysozyme and to phagocytosis.
    Folia Microbiol (Praha). 1968;13(5):439-49 PMID: 4880678
  232. Evaluation of a technique for the estimation of serum bactericidal activity against Gram-negative organisms.
    Med Lab Technol. 1972 Jul;29(3):272-9 PMID: 4561824
  233. Studies on natural antibodies to gram-negative bacteria.
    J Exp Med. 1962 Jan 1;115:131-46 PMID: 14473316
  234. Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.
    J Clin Invest. 1976 Nov;58(5):1163-73 PMID: 825532
  235. COMPARISON OF SOME PROPERTIES OF PSEUDOMONAS AERUGINOSA ISOLATED FROM INFECTIONS IN PERSONS WITH AND WITHOUT CYSTIC FIBROSIS.
    J Bacteriol. 1964 Feb;87:427-31 PMID: 14151067
  236. Role of blocking antibody in disseminated gonococcal infection.
    J Immunol. 1978 Nov;121(5):1884-8 PMID: 712069
  237. The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli.
    J Immunol. 1969 Jun;102(6):1379-87 PMID: 4891549
  238. The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction.
    Proc Soc Exp Biol Med. 1970 Jan;133(1):345-8 PMID: 4904564
  239. SERUM BACTERICIDAL ACTIVITY IN PATIENTS WITH PYELONEPHRITIS.
    Am J Med Sci. 1964 Sep;248:285-9 PMID: 14210304
  240. Facile penetration of the Staphylococcus aureus capsule by lysostaphin.
    Infect Immun. 1980 Sep;29(3):892-6 PMID: 7429637
  241. Increase in specific bactericidal antibodies after administration of endotoxin.
    Nature. 1961 Jul 15;191:296-7 PMID: 13770153
  242. An antibactericidal factor in the serum of two patients with infections of the upper urinary tract.
    Clin Sci. 1972 Jul;43(1):23-30 PMID: 4557281
  243. Membranolysis by the ninth component of human complement.
    Biochem Biophys Res Commun. 1981 Jun 16;100(3):1409-14 PMID: 7271808
  244. Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity.
    Infect Immun. 1978 Apr;20(1):267-72 PMID: 78895
  245. Experimental endocarditis in rabbits. 4. Experiments with Serratia marcescens: on the significance of serum susceptibility and proteolytic capacity of the strains and the influence of an indwelling catheter.
    Acta Pathol Microbiol Scand B. 1980 Oct;88(5):269-76 PMID: 7008497
  246. Effect of colicin K on a membrane-associated, energy-linked function.
    J Bacteriol. 1976 May;126(2):601-8 PMID: 4429
  247. [Recurrent meningococcal meningitis associated with complement C6 deficiency (author's transl)].
    Nouv Presse Med. 1981 Oct 17;10(37):3057-9 PMID: 7290963
  248. The serum bactericidal reaction. IV. Phenotypic conversion of Escherichia coli from serum-resistance to serum-sensitivity by diphenylamine.
    J Infect Dis. 1969 Oct;120(4):437-44 PMID: 4898784
  249. MUTATIONS TO PENICILLIN RESISTANCE IN THE ENTEROBACTERIACEAE THAT AFFECT SENSITIVITY TO SERUM AND VIRULENCE FOR THE MOUSE.
    J Bacteriol. 1965 Mar;89:630-9 PMID: 14273637
  250. Detection of agents that alter the bacterial cell surface.
    Antimicrob Agents Chemother. 1975 Jul;8(1):34-7 PMID: 169728
  251. Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.
    J Med Microbiol. 1979 Feb;12(1):123-30 PMID: 372531
  252. Role of surface components in serum resistance of virulent Aeromonas salmonicida.
    Infect Immun. 1982 Jun;36(3):1069-75 PMID: 7095843
  253. Rapidly induced changes in the level of non-specific immunity in laboratory animals.
    Br J Exp Pathol. 1956 Jun;37(3):223-34 PMID: 13342346
  254. The effects of serum components on the agglutination of Gram-negative bacteria.
    Can J Microbiol. 1970 Feb;16(2):121-4 PMID: 4984774
  255. Bactericidal activity of normal serum against bacterial cultures. I. Activity against Salmonella typhi strains.
    Proc Soc Exp Biol Med. 1958 Feb;97(2):376-82 PMID: 13518280
  256. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
    Clin Exp Immunol. 1978 Jul;33(1):115-21 PMID: 361314
  257. Passive sensitization of Salmonella adelaide to the bactericidal action of antibody and complement.
    Nature. 1968 Feb 17;217(5129):657-8 PMID: 4170308
  258. Analysis of sequential stages in serum bactericidal reactions.
    J Bacteriol. 1964 May;87(5):1067-72 PMID: 5334967
  259. Bactericidal activity of standard bovine serum against coliform bacteria isolated from udders and the environment of dairy cows.
    Am J Vet Res. 1977 Dec;38(12):2019-22 PMID: 339792
  260. Characteristics of complement-dependent release of phospholipid from Escherichia coli.
    Infect Immun. 1971 Jul;4(1):23-8 PMID: 5005285
  261. Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli.
    Infect Immun. 1974 Sep;10(3):657-66 PMID: 4609906
  262. Humoral and cellular aspects of the immune response to the somatic antigen of Salmonella enteritidis.
    J Exp Med. 1965 Sep 1;122(3):483-504 PMID: 5839282
  263. Relationships between bacterial resistance to serum and penicillin.
    Proc Soc Exp Biol Med. 1958 Jan;97(1):104-7 PMID: 13518191
  264. Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria.
    J Infect Dis. 1978 Sep;138(3):359-68 PMID: 100562
  265. Basis for the selectivity of action of the polymyxin antibiotics on cell membranes.
    Ann N Y Acad Sci. 1974 May 10;235(0):480-92 PMID: 4368447
  266. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.
    J Exp Med. 1970 Apr 1;131(4):643-57 PMID: 4193935
  267. Radiobacteriolysis: a new technique using chromium-51 for assaying anti-Vibrio cholerae antibodies.
    Infect Immun. 1973 Jan;7(1):53-61 PMID: 4570279
  268. Genetical studies of serum resistance in Escherichia coli.
    J Gen Microbiol. 1975 Jul;89(1):57-66 PMID: 1097595
  269. The complement lysozyme sequence in immune bacteriolysis.
    Immunology. 1969 Apr;16(4):463-71 PMID: 4890313
  270. The complement-dependent bacteriolytic activity of normal human serum. I. The effect of pH and ionic strength and the role of lysozyme.
    J Exp Med. 1962 Jun 1;115:1231-49 PMID: 14004953
  271. Biological Activities of Rabbit Immunoglobulin M and Immunoglobulin G Antibodies to Pseudomonas aeruginosa.
    Infect Immun. 1970 Oct;2(4):453-61 PMID: 16557861
  272. Complement fixation on cell surfaces by 19S and 7S antibodies.
    Science. 1965 Oct 22;150(3695):505-6 PMID: 5319759
  273. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.
    J Exp Med. 1979 Apr 1;149(4):870-82 PMID: 372483
  274. Isolation and properties of complement-resistant strains of Escherichia coli K-12.
    Infect Immun. 1977 Nov;18(2):446-53 PMID: 336545
  275. Editorial: Host response in urinary tract infections.
    Kidney Int. 1974 Mar;5(3):179-86 PMID: 4594798
  276. Metabolically controlled killing of Pasteurella septica by antibody and complement.
    Biochim Biophys Acta. 1974 Oct 8;362(3):598-601 PMID: 4472199
  277. Genetic mapping of the K1 and K4 antigens (L) of Escherichia coli. Non-allelism of K(L) antigens with K antigens of O8:K27(A), O8:K8(L) and O9:K57(B).
    Acta Pathol Microbiol Scand B. 1976 Jun;84(3):125-31 PMID: 793292
  278. A protein factor associated with serum resistance in Escherichia coli.
    J Med Microbiol. 1977 May;10(2):225-32 PMID: 323489
  279. A factor in the serum of patients with persisting infection that inhibits the bactericidal activity of normal serum against the organism that is causing the infection.
    J Immunol. 1966 Sep;97(3):431-7 PMID: 5332981
  280. Inhibition of serum bactericidal activity by bilirubin.
    Immunol Lett. 1982 Feb;4(2):103-5 PMID: 7037625
Article Info
Journal
Microbiological reviews
Abbr.
Microbiol Rev
ISSN
0146-0749
DOI
10.1128/mr.47.1.46-83.1983
Published
1983-03-00
Pages
46-83
Language
English
Region
United States
NLM ID
7806086
PMCID
PMC281561
Subset
IM
External Links
PubMed source DOI: 10.1128/mr.47.1.46-83.1983 PMC Full Text
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2